Similar articles for PMID: 21896148

Year	Number of Results
1985	1
1987	1
1988	2
1989	3
1990	1
1991	2
1995	2
1996	1
1997	3
1998	2
1999	1
2000	1
2001	4
2002	4
2003	4
2004	8
2005	3
2006	6
2007	5
2008	2
2009	3
2010	4
2011	5
2012	6
2013	6
2014	6
2015	3
2016	3
2017	4
2018	7
2019	1
2020	1
2021	1
2022	2
2023	1
2024	0

1

Angiotensin-converting enzyme inhibitors.

Izzo JL Jr, Weir MR. Izzo JL Jr, et al. J Clin Hypertens (Greenwich). 2011 Sep;13(9):667-75. doi: 10.1111/j.1751-7176.2011.00508.x. Epub 2011 Jul 18. J Clin Hypertens (Greenwich). 2011. PMID: 21896148 Free PMC article. Review.

2

Resistant Hypertension On Treatment (ResHypOT): sequential nephron blockade compared to dual blockade of the renin-angiotensin-aldosterone system plus bisoprolol in the treatment of resistant arterial hypertension - study protocol for a randomized controlled trial.

Cestário EDES, Fernandes LAB, Giollo-Júnior LT, Uyemura JRR, Matarucco CSS, Landim MIP, Cosenso-Martin LN, Tácito LHB, Moreno H Jr, Vilela-Martin JF, Yugar-Toledo JC. Cestário EDES, et al. Trials. 2018 Feb 12;19(1):101. doi: 10.1186/s13063-017-2343-3. Trials. 2018. PMID: 29433578 Free PMC article.

3

The effect of ramipril and telmisartan on serum potassium and its association with cardiovascular and renal events: results from the ONTARGET trial.

Heerspink HJ, Gao P, de Zeeuw D, Clase C, Dagenais GR, Sleight P, Lonn E, Teo KT, Yusuf S, Mann JF. Heerspink HJ, et al. Eur J Prev Cardiol. 2014 Mar;21(3):299-309. doi: 10.1177/2047487313510678. Epub 2013 Nov 4. Eur J Prev Cardiol. 2014. PMID: 24191305 Clinical Trial.

4

Angiotensin II receptor antagonists and heart failure: angiotensin-converting-enzyme inhibitors remain the first-line option.

[No authors listed] [No authors listed] Prescrire Int. 2005 Oct;14(79):180-6. Prescrire Int. 2005. PMID: 16285075

5

[Angiotensin-converting enzyme inhibitors. Principles and rules of use].

Eicher JC, Wolf JE. Eicher JC, et al. Rev Prat. 1998 Apr 1;48(7):771-6. Rev Prat. 1998. PMID: 11767373 Review. French. No abstract available.

6

Antihypertensive Medications and the Prevalence of Hyperkalemia in a Large Health System.

Chang AR, Sang Y, Leddy J, Yahya T, Kirchner HL, Inker LA, Matsushita K, Ballew SH, Coresh J, Grams ME. Chang AR, et al. Hypertension. 2016 Jun;67(6):1181-8. doi: 10.1161/HYPERTENSIONAHA.116.07363. Epub 2016 Apr 11. Hypertension. 2016. PMID: 27067721 Free PMC article.

7

Angiotensin-Converting Enzyme Inhibitors in Hypertension: To Use or Not to Use?

Messerli FH, Bangalore S, Bavishi C, Rimoldi SF. Messerli FH, et al. J Am Coll Cardiol. 2018 Apr 3;71(13):1474-1482. doi: 10.1016/j.jacc.2018.01.058. J Am Coll Cardiol. 2018. PMID: 29598869 Free article. Review.

8

Pharmacotherapy: Optimal blockade of the renin-angiotensin-aldosterone system.

Nussberger J, Bohlender J. Nussberger J, et al. Nat Rev Cardiol. 2013 Apr;10(4):183-4. doi: 10.1038/nrcardio.2013.28. Epub 2013 Mar 12. Nat Rev Cardiol. 2013. PMID: 23478259

9

Use of angiotensin-converting enzyme inhibitors in patients with heart failure and renal insufficiency: how concerned should we be by the rise in serum creatinine?

Ahmed A. Ahmed A. J Am Geriatr Soc. 2002 Jul;50(7):1297-300. doi: 10.1046/j.1532-5415.2002.50321.x. J Am Geriatr Soc. 2002. PMID: 12133029

10

Updates on the treatment of essential hypertension: a summary of AHRQ's comparative effectiveness review of angiotensin-converting enzyme inhibitors, angiotensin II receptor blockers, and direct renin inhibitors.

Powers B, Greene L, Balfe LM. Powers B, et al. J Manag Care Pharm. 2011 Oct;17(8 Suppl):S1-14. doi: 10.18553/jmcp.2011.17.s8.1. J Manag Care Pharm. 2011. PMID: 22088101 Free PMC article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

101 results

Results by year